The study also showed that Parkin overexpression increased mitochondrial fission, whereas Drp1 overexpression increased mitophagic flux, suggesting that interventions promoting mitochondrial fission and mitophagy, without aberrant activation of the processes, can be therapeutic in mitigating diabetic cardiomyopathy. Here, PRKN is linked to diabetic cardiomyopathy.